MedPath

TOUJEO DOUBLESTAR

TOUJEO DOUBLESTAR

Approved
DIN Number

02493373

Drug Class

Human

Market Date

Feb 4, 2020

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02493373
AIG Number0147062002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AE04 INSULIN GLARGINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

INSULIN GLARGINEActive
Strength: 300 UNIT / ML
Monograph: INSULIN GLARGINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.